• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

ASTMH 2010

3-7 November 2010

Atlanta, USA

The Drugs for Neglected Diseases initiative (DNDi) will participate in several activities at ASTMH 2010, including a joint symposium with Central Drug Research Institute (CDRI)on Visheral Leishmaniasis (VL) in the Indian Continent, a second symposium on VL in East Africa, a satellite symposium on Challenges and Successes of the FACT Project through Innovative Partnerships for the development of Artesunate Combination Therapies for Malaria, as well as several oral presentations.

Symposia

•    Friday, November 05, 2010 (1:30pm—3:15pm)

Title: Current Challenges and Opportunities in managing Visceral Leishmaniasis in the Indian subcontinent

Jointly organized by Drugs for Neglected Diseases initiative (DNDi) & Central Drug Research Institute (CDRI)

Chair: Prof. Kwang Poo Chang, Rosalind Franklin University of Medicine and Science, USA
Co-chair: Prof. Farrokh Modabber; Drugs for Neglected Diseases initiative (DNDi), Switzerland

Speakers:
puce Profs Kwang Poo Chang & Farrokh Modabber: Opening Remarks
puce Prof. Shyam Sundar (Banaras Hindu University, India): General Introduction and Current Clinical Management of VL in the Indian subcontinent
puce Prof Farrokh Modabber (DNDi, Switzerland): Potential new treatment options for VL: Combination therapy with liposomal amphotericin B, miltefosine and paromomycin
puce Dr. Larry Ming C. Chow (Hong Kong Polytechnic University Hong Kong): Strategies of reversing drug-resistance by using flavinoid dimmers
puce Prof. K.P. Chang (Chicago Medical School/RFUMS, USA): Therapeutic/prophylactic strategies with minimal risks of eliciting drug-resistance – Photomedicine
puce Dr. Neeloo Singh (Central Drug Research Institute, India): Analysis of drug resistance in clinical isolates
puce Panel members: Profs Jorger Alvar, Piero Olliaro: Panel discussion and question and answers

•   Saturday, November 06, 2010 (1:30pm—3:15pm)

Title: VL in East Africa- Current Needs and Latest Clinical Developments

Jointly organized by Drugs for Neglected Diseases initiative (DNDi) &  Leishmania East Africa Platform (LEAP)

Chair: Prof. Ahmed El Hassan, University of Khartoum, Sudan
Co-chair: Prof. Joseph Olobo, Makerere University, Kampala, Uganda

Speakers:
puce Dr. Monique Wasunna (Kenya Medical Research Institute, KEMRI): Leishmania East Africa Platform: a model for a clinical research platform in Africa
puce Dr. Manica Balasegaram (DNDi): Economic analysis of visceral leishmaniasis control in Sudan
puce Prof. Asrat Hailu (Addis Ababa University, Ethiopia): Ambisome: The experience in East Africa 
puce Dr. Ahmed Mudawi Musa (University of Khartoum, Sudan): A multicentre comparative trial of efficacy and safety of sodium stibogluconate (SSG), paromomycin (PM) and the combination of SSG and pM as first-line treatment for visceral leishmaniasis in East Africa

Satellite Symposium

•    Friday, November 05, 2010 (7:15pm—9:00pm)

Title: Challenges and Successes of the FACT Project through Innovative Partnerships for the Development of Artesunate Combination Therapies for Malaria

Chair: Chair: Prof. Nicholas White (Wellcome Trust Mahidol University, Bangkok, Thailand)
Co-chair: Dr. Piero Olliaro (WHO/TDR, Geneva, Switzerland)

Speakers:
puce Dr. Jean-René Kiechel (DNDi): Partnerships: The Way to Successful Antimalarial Development
puce Dr. Francois Bompart (sanofi-aventis, Paris, France): Public-Private Partnerships for ACT Development and Field Implementation
puce Dr. Ana Carolina Santelli (Brasilian Malaria Control Programme, Brazil): Implementation of ASMQ – Brazilian experience
puce Dr. Neena Valecha (National Institute of Malaria Research, New Delhi, India): Partnership in India and Beyond
puce Dr. Bernard Pécoul (DNDi): What Next? The Future of Partnerships

Booth

DNDi’s booth is #408. Please visit our team there to receive information about DNDi’s activities.

Other events

Loading...
11-13 October 2026

Berlin, Germany & Online

World Health Summit 2026

14-17 September

Copenhagen, Denmark

Hepatitis C virus, flaviviruses and related viruses (HCV-Flavi) 2026

25-28 August 2026

Addis Ababa, Ethiopia

Seventy-sixth session of the WHO Regional Committee for Africa

16-19 August 2026

Brasilia, Brazil

61st Congress of the Brazilian Society of Tropical Medicine (Medtrop 2026)

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Youtube Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license